ESM1 and glioblastoma: The reason for this is unclear, but we speculate that Endocan may act together with PDGF-BB to maintain a high level of PDGFRa activation in the same tumor region, while other PDGFR ligands are expressed in the different GBM areas and may therefore affect other populations of GBM cells.